Brief: Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results And Operational Highlights
Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS REPORTS FIRST QUARTER 2022
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* Q1 LOSS PER SHARE $0.21
* AS OF MARCH 31, 2022, CASH AND CASH EQUIVALENTS WERE $69.7
MILLION, COMPARED TO $67.8 MILLION AS OF DECEMBER 31, 2021
* Q1 EARNINGS PER SHARE VIEW $-0.23 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5FTHw7
Further company coverage: ZYNE.O
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary